Speech therapy of dysarthria in Parkinson's disease

被引：0
|
作者：
Cabrejo, L
Auzou, P
Ozsancak, C
Hannequin, D [1 ]
机构：
[1] CHU Charles Nicolle, Dept Neurol, F-76000 Rouen, France
[2] Grp Hopale, Serv Explorat Fonct Neurol, Berck Sur Mer, France
[3] CHRU, Serv Neurol, F-59 Lille, France
来源：
PRESSE MEDICALE | 2003年 / 32卷 / 37期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Speech therapy of dysarthria in Parkinson's disease. The treatment of speech impairment a factor of loneliness, speech therapy to treat dysarthria in Parkinson's disease is a fundamental aspect of patient management. The impact of medicinal treatment of dysarthria is controversial and surgery appears to worsen the problem. Various speech therapy approaches are relaxation, postural rehabilitation, respiration, phonation, articulation and prosodic re-education. An interesting method: This overview underlines the fundamental principles of speech therapy in Parkinson's disease and compares the main methods and their results. We particularly insist on the Lee Silverman Voice Treatment (LSVT), phonation re-education method that has been widely developed in the United-States. Our aim is to provide better knowledge on this re-education method in France.
引用
收藏
页码：1745 / 1751
页数：7
相关论文
共 50 条
  • [31] Guidelines for Speech-Language Therapy in Parkinson's Disease
    Kalf, J. G.
    de Swart, B. J. M.
    Bloem, B. R.
    Munneke, M.
    [J]. MOVEMENT DISORDERS, 2010, 25 : S711 - S711
  • [32] Speech and language therapy provision for people with Parkinson's disease
    Noble, Emma
    Jones, Diana
    Miller, Nick
    Burn, David
    [J]. INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2006, 13 (07): : 323 - 327
  • [33] Guidelines for speech-language therapy in Parkinson's disease
    Kalf, J. G.
    De Swart, B-. J.
    Bloem, B. R.
    Munneke, M.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S328 - S329
  • [34] Guidelines for speech-language therapy in Parkinson's disease
    Kalf, J.
    De Swart, B.
    Bloem, B. R.
    Munneke, M.
    [J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 : S183 - S184
  • [35] The relevance efficacy of speech therapy, occupational therapy and physiotherapy in Parkinson's disease
    Fuchs, GA
    [J]. AKTUELLE NEUROLOGIE, 2003, 30 : S246 - S248
  • [36] The effects of bilateral subthalamic nucleus stimulation on motor speech function in a patient with severe dysarthria and Parkinson's disease
    Theodoros, DG
    Farrell, AM
    Ward, EC
    Silburn, P
    Hall, B
    [J]. MOVEMENT DISORDERS, 2002, 17 : S96 - S97
  • [37] Testing the applicability of the dysarthria analyzer to detect levodopa effects on speech in a German cohort of people with Parkinson's disease
    Thies, T.
    Schreen, J.
    Jergas, H.
    Barbe, M.
    [J]. MOVEMENT DISORDERS, 2023, 38 : S629 - S630
  • [38] Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease
    Herd, Clare P.
    Tomlinson, Claire L.
    Deane, Katherine H. O.
    Brady, Marian C.
    Smith, Christina H.
    Sackley, Catherine M.
    Clarke, Carl E.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (08):
  • [39] Individuals with Parkinson's disease and dysarthria define communicative effectiveness
    Donovan, N.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S189 - S190
  • [40] Improvement of voicing in patients with Parkinson's disease by speech therapy - Reply
    de Swart, BJM
    Willemse, SC
    Horstink, MWIM
    Maassen, BAM
    [J]. NEUROLOGY, 2003, 61 (09) : 1316 - 1317
12345